Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior B Perez Villamil, A Romera Lopez, S Hernandez Prieto, G Lopez Campos, ... BMC cancer 12, 1-13, 2012 | 146 | 2012 |
Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II J Ruiz, A Martínez, S Hernández, H Zimman, M Ferrer, C Fernández, ... Histology and histopathology, 2010 | 63 | 2010 |
Neoadjuvant atezolizumab+ chemotherapy in resectable non-small cell lung cancer (NSCLC). CA Shu, C Grigg, C Chiuzan, RF Garofano, V Patel, S Hernandez, T Negri, ... Journal of Clinical Oncology 36 (15_suppl), 8532-8532, 2018 | 61 | 2018 |
Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non–small cell lung carcinoma: the ROSING study E Conde, S Hernandez, R Martinez, B Angulo, J De Castro, ... Journal of Thoracic Oncology 14 (12), 2120-2132, 2019 | 57 | 2019 |
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas E Conde, S Hernandez, M Prieto, R Martinez, F Lopez-Rios Expert review of molecular diagnostics 16 (6), 707-713, 2016 | 49 | 2016 |
3p21, 5q21, 9p21 and 17p13. 1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia. J Sanz-Ortega, S Hernández, MC Saez, E Sierra, G Sanz-Ortega, ... Hepato-gastroenterology 50 (50), 404-407, 2003 | 44 | 2003 |
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer S Hernández-Prieto, A Romera, M Ferrer, JL Subiza, JA López-Asenjo, ... Clinical and Translational Oncology 17, 330-338, 2015 | 38 | 2015 |
Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability P Ortega, A Morán, C de Juan, C Frías, S Hernández, JA López-Asenjo, ... Clinical cancer research 14 (4), 995-1001, 2008 | 38 | 2008 |
Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer E Conde, S Hernandez, E Sanchez, RM Regojo, C Camacho, M Alonso, ... Archives of Pathology & Laboratory Medicine 145 (8), 1031-1040, 2021 | 36 | 2021 |
3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation J Sanz Ortega, C Valor, MC Saez, L Ortega, E Sierra, J Poch, ... Histology and histopathology, 2003 | 36 | 2003 |
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care I Del-Cura González, F García-de-Blas González, TS Cuesta, ... BMC public health 11, 1-8, 2011 | 34 | 2011 |
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care IDC González, FGB González, TS Cuesta, JM Fernández, ... BMC Public Health 11, 63, 2011 | 21 | 2011 |
Aligning digital CD8+ scoring and targeted next‐generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early‐stage … E Conde, A Caminoa, C Dominguez, A Calles, S Walter, B Angulo, ... Histopathology 72 (2), 270-284, 2018 | 18 | 2018 |
CIPROFLOXACIN IN TREATMENT OF NONSPECIFIC VAGINITIS O Carmona, R KOBELT, S HERNANDEZ, I GONZALEZ, LH GRAFFE ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA 37 (1), 72-72, 1987 | 14 | 1987 |
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. S Khan, J Lutzky, AN Shoushtari, JM Jeter, C Chiuzan, N Sender, ... Journal of Clinical Oncology 38 (15_suppl), 10075-10075, 2020 | 13 | 2020 |
Evaluación, formación e innovación docente: respuesta a la mejora de calidad universitaria MJ Rodríguez, S Olmos, F Ortega, P Torrijos, S Hernández Revista CIDUI 2, 2014 | 12 | 2014 |
Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition T Fernández-Marcelo, A Morán, C De Juan, I Pascua, J Head, A Gómez, ... Oncology 82 (3), 153-164, 2012 | 11 | 2012 |
Screening for ROS1 fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody E Conde, S Hernandez, A Benito, A Caminoa, P Garrido, F Lopez-Rios Expert Review of Molecular Diagnostics 21 (5), 437-444, 2021 | 10 | 2021 |
Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice J Zugazagoitia, J Puente, JL González-Larriba, A Manzano, M Sotelo, ... Oncology 84 (5), 255-264, 2013 | 9 | 2013 |
Quilty effect areas are frequently associated with endocardial C4d deposition LC Cano, AA Arteta, R Fernández, JAL García-Asenjo, S Hernández, ... The Journal of heart and lung transplantation 27 (7), 775-779, 2008 | 9 | 2008 |